| Bilirubin in the liver–gut signaling axis AR Hamoud, L Weaver, DE Stec, TD Hinds Trends in Endocrinology & Metabolism 29 (3), 140-150, 2018 | 245 | 2018 |
| Bilirubin binding to PPARα inhibits lipid accumulation DE Stec, K John, CJ Trabbic, A Luniwal, MW Hankins, J Baum, ... PloS one 11 (4), e0153427, 2016 | 212 | 2016 |
| Protein phosphatase 5 TD Hinds Jr, ER Sánchez The international journal of biochemistry & cell biology 40 (11), 2358-2362, 2008 | 180 | 2008 |
| Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways OO Badmus, SA Hillhouse, CD Anderson, TD Hinds Jr, DE Stec Clinical science 136 (18), 1347-1366, 2022 | 172 | 2022 |
| Bilirubin as a metabolic hormone: the physiological relevance of low levels JF Creeden, DM Gordon, DE Stec, TD Hinds Jr American Journal of Physiology-Endocrinology and Metabolism 320 (2), E191-E207, 2021 | 171 | 2021 |
| The glucocorticoid receptor: cause of or cure for obesity? K John, JS Marino, ER Sanchez, TD Hinds Jr American Journal of Physiology-Endocrinology and Metabolism 310 (4), E249-E257, 2016 | 165 | 2016 |
| Discovery of glucocorticoid receptor-β in mice with a role in metabolism TD Hinds Jr, S Ramakrishnan, HA Cash, LA Stechschulte, G Heinrich, ... Molecular endocrinology 24 (9), 1715-1727, 2010 | 151 | 2010 |
| FKBP51 and Cyp40 are positive regulators of androgen-dependent prostate cancer cell growth and the targets of FK506 and cyclosporin A S Periyasamy, T Hinds, L Shemshedini, W Shou, ER Sanchez Oncogene 29 (11), 1691-1701, 2010 | 150 | 2010 |
| Biliverdin reductase isozymes in metabolism L O’Brien, PA Hosick, K John, DE Stec, TD Hinds Trends in Endocrinology & Metabolism 26 (4), 212-220, 2015 | 149 | 2015 |
| Biliverdin reductase A attenuates hepatic steatosis by inhibition of glycogen synthase kinase (GSK) 3β phosphorylation of serine 73 of peroxisome proliferator-activated … TD Hinds, KA Burns, PA Hosick, L McBeth, A Nestor-Kalinoski, ... Journal of Biological Chemistry 291 (48), 25179-25191, 2016 | 140 | 2016 |
| Retracted: Increased HO‐1 levels ameliorate fatty liver development through a reduction of heme and recruitment of FGF21 TD Hinds Jr, K Sodhi, C Meadows, L Fedorova, N Puri, DH Kim, ... Obesity 22 (3), 705-712, 2014 | 114 | 2014 |
| Protein phosphatase 5 mediates lipid metabolism through reciprocal control of glucocorticoid receptor and peroxisome proliferator-activated receptor-γ (PPARγ) TD Hinds, LA Stechschulte, HA Cash, D Whisler, A Banerjee, W Yong, ... Journal of Biological Chemistry 286 (50), 42911-42922, 2011 | 113 | 2011 |
| Bilirubin, a cardiometabolic signaling molecule TD Hinds Jr, DE Stec Hypertension 72 (4), 788-795, 2018 | 110 | 2018 |
| Mice with hyperbilirubinemia due to Gilbert’s syndrome polymorphism are resistant to hepatic steatosis by decreased serine 73 phosphorylation of PPARα TD Hinds Jr, PA Hosick, S Chen, RH Tukey, MW Hankins, ... American Journal of Physiology-Endocrinology and Metabolism 312 (4), E244-E252, 2017 | 103 | 2017 |
| Increased heme-oxygenase 1 expression in mesenchymal stem cell-derived adipocytes decreases differentiation and lipid accumulation via upregulation of the canonical Wnt … L Vanella, K Sodhi, DH Kim, N Puri, M Maheshwari, TD Hinds, L Bellner, ... Stem cell research & therapy 4, 1-14, 2013 | 99 | 2013 |
| Biliverdin reductase and bilirubin in hepatic disease L Weaver, A Hamoud, DE Stec, TD Hinds Jr American Journal of Physiology-Gastrointestinal and Liver Physiology 314 (6 …, 2018 | 98 | 2018 |
| FKBP51 null mice are resistant to diet-induced obesity and the PPARγ agonist rosiglitazone LA Stechschulte, B Qiu, M Warrier, TD Hinds Jr, M Zhang, H Gu, Y Xu, ... Endocrinology 157 (10), 3888-3900, 2016 | 97 | 2016 |
| Loss of hepatic PPARα promotes inflammation and serum hyperlipidemia in diet-induced obesity DE Stec, DM Gordon, JA Hipp, S Hong, ZL Mitchell, NR Franco, ... American Journal of Physiology-Regulatory, Integrative and Comparative …, 2019 | 94 | 2019 |
| Glucocorticoid Receptor β Induces Hepatic Steatosis by Augmenting Inflammation and Inhibition of the Peroxisome Proliferator-activated Receptor (PPAR) α*♦ JS Marino, LA Stechschulte, DE Stec, A Nestor-Kalinoski, S Coleman, ... Journal of Biological Chemistry 291 (50), 25776-25788, 2016 | 93 | 2016 |
| Control of glucocorticoid and progesterone receptor subcellular localization by the ligand-binding domain is mediated by distinct interactions with tetratricopeptide repeat … A Banerjee, S Periyasamy, IM Wolf, TD Hinds Jr, W Yong, W Shou, ... Biochemistry 47 (39), 10471-10480, 2008 | 84 | 2008 |